BCC 2023 | De-escalation of axillary radiotherapy in early breast cancer

Icro Meattini, MD, University of Florence, Florence, Italy, discusses de-escalation of axillary radiotherapy, highlighting lower-risk patients that receive upfront surgery, high-risk patients that receive upfront surgery, and patients that obtain a pathological complete response after primary systemic therapy as three different patient populations that may be considered for de-escalation of axililary radiotherapy. This interview took place at the St. Gallen International Breast Cancer Consensus Meeting in Vienna, Austria.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.